At the crossroad of nanotechnology and cancer cell membrane coating: Expanding horizons with engineered nanoplatforms for advanced cancer therapy harnessing homologous tumor targeting-Reference-Cited by-同舟云学术

At the crossroad of nanotechnology and cancer cell membrane coating: Expanding horizons with engineered nanoplatforms for advanced cancer therapy harnessing homologous tumor targeting

Published:2024-05 Issue: Volume:506 Page:215712
ISSN:0010-8545
Container-title:Coordination Chemistry Reviews
language:en
Short-container-title:Coordination Chemistry Reviews

Author:

Pan Huachun^ORCID,Yang Shumin^ORCID,Gao Lun,Zhou Jinzhao,Cheng Wenke,Chen Gang,Shuhang Wang,Li Ning,Veranič Peter,Musiol Robert,Cai Qiang,Shubhra Quazi T.H.

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference178 articles.

1. Lipid-core nanoparticles: Classification, preparation methods, routes of administration and recent advances in cancer treatment;Graván;Advances in Colloid and Interface Science,2023

2. Application of nano/microencapsulated phenolic compounds against cancer;Rahaiee;Advances in Colloid and Interface Science,2020

3. Integrating Nanotechnology into Cancer Care;Grodzinski;ACS Nano,2019

4. Radioiodine based biomedical carriers for cancer theranostics;Guo;Coordination Chemistry Reviews,2023

5. Multivesicular Liposome (Depofoam) in Human Diseases;Salehi;Iran J Pharm Res,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A biomimetic targeted nanosystem delivering synergistic inhibitors for glioblastoma immune microenvironment reprogramming and treatment;Materials Today Bio;2024-10

2. Cancer cell membrane-modified Soluplus® micelles for gemcitabine delivery to pancreatic cancer using a prodrug approach;International Journal of Pharmaceutics;2024-09

3. Pre-activated macrophage membrane-encased aggregation-induced emission featuring nanoparticles: a novel possibility for tuberculosis treatment;Signal Transduction and Targeted Therapy;2024-06-26

4. A minimalist cancer cell membrane-shielded biomimetic nanoparticle for nasopharyngeal carcinoma active-targeting therapy;Colloids and Surfaces B: Biointerfaces;2024-06

5. Eclipsing Toxicity, Enhancing Efficacy: Clofazimine’s Vanguard in the Realm of Anti-PD-1 and CTLA-4 Immunotherapy;Research;2024-01